Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Embark Veterinary Inc. is active in the Biotechnology & Pharmaceuticals technology area. The company currently has 1 pending office action under review at the USPTO. This matter is being handled by 1 distinct examiner, AUGER, NOAH ANDREW, in 1 distinct art unit. Because AUGER, NOAH ANDREW is the busiest examiner with 1 busiest examiner pending, this individual is the central figure in the company's current prosecution efforts. The concentration of the workload in 1 distinct art unit indicates a specific biotechnological focus.
With only 1 pending office action, the portfolio is in a phase of limited but focused growth. Practitioners should focus on the specific procedural tendencies of the 1 distinct examiner assigned to this case. The absence of multiple examiner perspectives means there is no internal baseline for comparing examiner behavior. Consequently, the immediate success of the company's patent strategy depends on the interactions with AUGER, NOAH ANDREW. Every response to the 1 pending office action must be carefully tailored to the specific examination style of the 1 distinct examiner involved. This concentration means that the company's immediate patent prospects are shaped by a single individual's interpretation.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AUGER, NOAH ANDREW | 1 | 36.4% | +42.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17896355 | METHODS AND SYSTEMS FOR DETERMINING ANCESTRAL RELATEDNESS | AUGER, NOAH ANDREW | 34d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17896355 | METHODS AND SYSTEMS FOR DETERMINING ANCESTRAL RELATEDNESS | AUGER, NOAH ANDREW | 34d |
| Art Unit | Apps |
|---|---|
| 1687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17896355 | METHODS AND SYSTEMS FOR DETERMINING ANCESTRAL RELATEDNESS | AUGER, NOAH ANDREW | 1687 | §101§112Other | Non-Final OA | 34d | Pending | Aug 26, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial